Ear, Nose and Throat (ENT) News and Research

RSS

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

What is the association between PASC-AMs and the diagnosis of new-onset psychiatric illness after acute SARS-CoV-2 infections?

Researchers investigated if non-psychiatric PASC-AMs increase the risk of new-onset psychiatric illness diagnosis.

12 Jul 2022

Sniffer dogs detect long COVID after 1.5 years

Researchers used sniffer dogs to test the presence of SARS-CoV-2 infection in axillary sweat samples of long COVID-19 patients.

17 Jan 2022

“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

A new study discusses the entry of SARS-CoV-2 into the respiratory and olfactory mucosa of the nasal cavity.

4 Nov 2021

Bone Conduction Kit may enable children and their parents to manage glue ear effectively at home

A wireless kit, comprising headphones, a microphone, and an app might be a cheap alternative to the usual treatment of the common temporary hearing loss in kids, popularly known as 'glue ear,' finds a small study, published in the online journal BMJ Innovations.

5 Oct 2021

One in four people could face some degree of hearing loss by 2050, WHO report warns

One in four people across the world — nearly 2.5 billion — could face some degree of hearing loss by 2050 with at least 700 million requiring access to treatment and rehabilitation, a WHO report warns.

11 Mar 2021

COVID-19 swab testing may not be good for people with a history of sinus or skull-base surgery

People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates.

4 Mar 2021

Essential oils from Greek herbs may protect against COVID-19

Researchers in Greece have demonstrated the antiviral effects of Cretan aromatic plant oils on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for coronavirus disease 2019 (COVID-19).

18 Jan 2021

Study shows evidence-based patient education is important in tinnitus

About 50 million people in the United States suffer with tinnitus, a condition in which people perceive sounds such as ringing or buzzing in their ears or head. It is the number one service-related disability among U.S. veterans.

12 Oct 2020

Anosmia (loss of smell) confirmed as a clinical feature of COVID-19

Earlier last month, the association of ear, nose, and throat (ENT) specialists in the UK issued a public statement advising patients with a sudden loss of smell or taste to get tested for COVID-19. They cited not only their own observations but those from numerous other ENT consultants the world around. A review of multiple papers on the sinus and nasal symptoms and signs related to the diagnosis of COVID-19, published in April 2020, in the journal Laryngoscope Investigative Otolaryngology, reiterates this finding.

15 Apr 2020

COVID19 patients describe a loss of smell and taste

Some medical specialists think that the sudden inability to smell or taste familiar odors and flavors could be an early sign of the novel coronavirus infection. This sign could be as innocuous-looking as feeling that food suddenly tastes bland, or that familiar strong smells aren't getting through. Yet, it could signal the need to isolate oneself because it is a little-known yet characteristic sign of COVID-19, the disease caused by the novel coronavirus that is racing around the world.

23 Mar 2020

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat diseases, today announced the presentation of Phase 1 clinical data for the company's lead therapeutic, LYR-210, for chronic rhinosinusitis, a debilitating disease caused by inflammation of the paranasal sinus tissues that affects approximately 27 million people, or 11% of the adult population in the U.S.

8 Oct 2018

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Novus Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, announced receipt of final meeting minutes from the U.S. Food and Drug Administration following a Type C meeting held at the Company's request to discuss its OP-02 development program in otitis media.

19 Jun 2018

Eating honey can reduce serious injuries in children who swallowed button battery, shows study

A team of ear, nose, and throat specialists has demonstrated that eating honey after swallowing a button battery has the potential to reduce serious injuries in small children.

11 Jun 2018

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

A team of researchers from the National University of Singapore has developed a novel handheld device, known as CLiKX, for the treatment of a condition called Otitis Media with Effusion, or 'glue ear', which is the leading cause of hearing loss and visits to the doctors among children worldwide.

24 May 2017

More than 1,000 patients at Sheffield Teaching Hospitals benefit from high-tech robot

More than 1,000 patients at Sheffield Teaching Hospitals have now benefitted from a high-tech robot that enables surgeons to perform highly precise and minimally-invasive surgery.

1 Feb 2017

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.

15 Dec 2015

Boston Scientific, Brainlab form strategic collaboration

Boston Scientific Corporation announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical navigation.

28 Apr 2015

Spirox closes $18.5 million Series B round of financing

Spirox Inc., a privately held medical device company, announced today the closing of an $18.5 million Series B round of financing led by Venrock and Aisling Capital. Existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participated in the round.

20 Apr 2015

Loyola otolaryngologist offers tips to identify, treat ear infection in children

Earaches in babies are not uncommon. But a baby's inability to communicate symptoms can leave most parents feeling helpless. According to the American Academy of Pediatrics, three-fourths of babies will get at least one ear infection before the age of one.

8 Apr 2015